Skip to content

Novavax NVAX Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin93.5%+23.2pp70.3%+5.2pp65.1%+10.6pp54.5%-45.5pp
Operating margin40.3%+76.8pp-36.5%+21.1pp-57.6%-25.1pp-32.5%+115pp
Net margin39.2%+66.7pp-27.5%+27.9pp-55.4%-22.2pp-33.2%+119pp
Efficiency
Asset turnover0.8×+0.4×0.4×-0.1×0.5×-0.3×0.8×+0.3×
Liquidity
Current ratio2.1×+1.1×+0.3×0.7×0.0×0.7×-0.2×
Leverage
Net debt / EBITDA0.1×
Per Share
Book value per share-$0.74+82.0%-$4.10+42.4%-$7.11+12.3%-$8.11-71.6%
Valuation
Market capitalization$1.46B+41.0%$1.29B+126%$570.19M-34.7%$873.84M-91.9%
Price / earnings2.5×
Price / sales2.5×+1.6×1.9×+1.3×0.6×+0.1×0.4×-9.0×
EV / EBITDA2.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Novavax's profit margins?
Novavax (NVAX) runs a 85.0% gross margin and a -13.1% operating margin, with a -14.7% net margin.
Where do Novavax's ratios come from?
Every ratio is computed from Novavax's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.